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Abstract
In the current era grown up congenital heart disease
(GUCH) patients undergoing surgical interventions are
increasing. Most of the interventions in the developed
countries are either complex or redo-operations in
patients who had previously undergone repair, palliation
or correction. However, in the developing countries most
of the interventions are primary and corrective. This
descriptive retrospective study comprised GUCH patients
who underwent surgical intervention for congenital heart
disease (CHD) at Aga Khan University Hospital, Karachi,
from January 2006 to December 2015. A total of 195
patients had been treated surgically with a mean age of
31.0±13.5 years. Majority of the patients underwent
surgical interventions for closure of atrial 109(55.3%) and
ventricular 51(26.2%) septal defect. The most common
complications were prolonged ventilation 16(8.1%).
Overall mortality was 4(2.1%). GUCH in our practice is for
primary procedure with simple diagnosis that should
have been treated before reaching adulthood as is done
in the developed countries.
Keywords: GUCH, CHD, Developing countries.
Introduction
Over the past century, massive breakthroughs have been
achieved incardiovascular diagnostics and cardiothoracic
surgery, leading to an increased survival of newborns with
congenital heart disease (CHD).1 Consequently, more
patients with CHD reach adulthood, creating a completely
new and steadily growing patient population with grown-
up CHD (GUCH).2 This is an inimitable challenge to
cardiologists, anaesthetists and cardiac surgeons.3
Careful, deliberate planning is crucial to transfer such
patients from paediatric care to the adult cardiology and
cardiothoracic surgery team. Birth defects are a global
problem, but their impact is particularly severe in low and
middle income countries (LMICs), where the conditions
for prevention, treatment, and rehabilitation are more
critical. Pakistan is LMIC in which approximately 40,000
babies are born with congenital cardiac defects annually.
Most commonly, primary and corrective CHD repairs are
done for atrial septal defect (ASD), ventricular septal
defect (VSD), tetralogy of fallot (TOF) and patent
ductusarteriosus (PDAs). On the other hand, literature
suggests that most of the interventions in the developed
countries are in the form of redo-operations in patients
who had previously undergone repair, palliation or
correction.2 However, in a developing country like ours,
most of the interventions are primary and corrective.
Outcome data for GUCH surgery in a developing country
like Pakistan is limited.We planned to study the frequency
and spectrum of GUCH patients who underwent
correction of congenital defect and to compare the GUCH
burden with developed counties.
Methods and Results
This descriptive retrospective study was conducted at the
Aga Khan University Hospital (AKUH), Karachi, and
comprised data of 195 GUCH patients aged 16 years or
above who underwent surgical intervention for CHD. Data
was acquired from the dedicated cardiac surgery database
over 10 years from January 2006 to December 2015. More
than 175(90%) surgical procedures had been performed
by paediatric cardiac surgeons as first-time surgeries.
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Figure: Trends of Grown Up Congenital Heart (GUCH) cases by year.
With regard to surgical strategy, ASD closure was
performed with autologous pericardial patch and VSD
closure with Dacron patch. The complete repair of TOF
consisted of closure of VSD and relief of right ventricular
outflow tract (RVOT) obstruction by muscle resection with
pulmonary valve reconstruction or replacement. Repair of
coarctation of aorta (CoA) was performed with end-to-
end anastomosis. Bidirectional Glenn shunt was
constructed for single-ventricle physiology.
The mean age of the patients was 31.0±13.8 years. There
were 96(49.2%) male and 99(50.8%) female patients. The
most prevalent procedure was ASD closure in 109(55.3%)
patients, followed by VSD closure 51(26.2%), TOF
25(12.8%), CoA 8(4.1%), 3(1.5%) each for PDA and other
congenital anomalies, and in 1(0.5%) case Glenn shunt
was performed. ASD was more prevalent in females
(p<0.05), whereas VSD and TOF were distinct in males
(p<0.05 each). Overall, 181(93%) patients were operated
for the repair of CHD for the first time. Hypertension was
common comorbidity in 36(18.8%) patients. Concomitant
repair or replacement of aortic valve was performed in
14(7.2%) patients, mitral 15(7.7%), tricuspid 3(1.5%) and
pulmonic 8(4.1%) cases. Intraoperative Median bypass
time was 81.5 minutes (intraquartile range [IQR]: 60-145),
and median cross clamp time was 55 minutes (IQR: 37-
100) (Table).
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Table: Pre and intraoperative clinical characteristics of GUCH patients by gender, n=195.
Characteristics Total Male Female P value*
n=195 n=96 (49.2%) n=99 (50.8%)
Age in years ±(SD) 31.0 ± 13.5 28.3 ± 12.0 33.6 ± 14.5 0.007
BMI kg/m2 22.1 ± 5.0 21.3 ± 4.4 22.9 ± 5.6 0.028
Comorbidities
Diabetes 8 (4.2) 3 (3.2) 5 (5.1) 0.722
Hypertension 36 (18.8) 14 (15.1) 22 (22.4) 0.202
Myocardial Infarction 9 (4.7) 5 (5.4) 4 (4.1) 0.742
Congestive Heart Failure 5 (2.6) 3 (3.3) 2 (2) 0.675
Arrhythmia 8 (4.1) 1 (1) 7 (7.1) 0.065
Ejection fraction <0.001
> 50% 171 (87.7) 83 (86.5) 88 (88.9)
30-50 % 18 (9.2) 9 (9.4) 9 (9.1)
< 30% 6 (3.1) 4 (4.2) 2 (2.0)
CHD anomalies†
ASD 109 (55.9) 36 (37.5) 73 (73.7) <0.001
VSD 51 (26.2) 39 (40.6) 12 (12.1) <0.001
TOF 25 (12.8) 17 (17.7) 8 (8.1) 0.054
CoA‡ 8 (4.1) 5 (5.2) 3 (3) 0.493
PDA 3 (1.5) 1 (1) 2 (2) 0.999
Glenn Shunt 1 (0.5) 0 (0) 1 (1) 0.999
Other congenital repair 3 (1.5) 1 (1) 2 (2) 0.999
Concomitant value replacement/repair
Aortic value 14 (7.2) 9 (9.4) 5 (5.1) 0.278
Mitral value 15 (7.7) 4 (4.2) 11 (11.1) 0.105
Tricuspid value 3 (1.5) 0 (0) 3 (3) 0.246
Pulmonic Value 8 (4.1) 6 (6.3) 2 (2) 0.165
First time surgery 181 (92.8) 89 (92.7) 92 (92.9) <0.001
Intra operative variables
Bypass time median IQR (min) 81.5 (60-145) 105 (65-175) 70 (50-120) <0.001
Cross clamp time median IQR (min) 55 (37-100) 70 (45-110) 48 (30-90) 0.002
Intra OP blood product used 82 (41.6) 37 (37.8) 45 (45.5) 0.273
*Independent samples t-test for continuous and Pearson Chi-square or Fisher's Exact test for categorical variables; mean and ± (SD) standard deviation or median (IQR) for skewed data where applied,
p values relate to group differences. Coarctation of aorta; †More than one anomalies may be present
BMI: Body mass index
ASD: Atrialseptal defect
VSD: Ventricular septal defect
TOF: Tetralogy of fallot
‡CoA: Coarctation of aorta
PDA: Patent ductusarteriosus.
Most common complication was prolonged ventilation
(>24 hours) in 16(8.1%) patients. Overall post-operative
morbidity was 27(14%).There were 4(2.1%) deaths; 2(1%)
each died of arrhythmia and septicaemia. Only 1(0.5%)
patient required re-operative procedure.
Conclusion
History of CHD management is an inspiring tale of
persistence, courage and ingenuity of pioneer cardiac
surgeons. However, their attempts were thwarted with a
mortality rate of about 85% for that era.4 With the
advancement in diagnostic imaging, preoperative
evaluation, careful intra-operative management and
improved postoperative care has led to an overall
decrease in mortality and increase in the survival of CHD
patients into adult hood.1 Putamen et al. studied 830
adults with CHD undergoing 963 procedures over a 17
year period and concluded that surgery can be performed
safely with low mortality and limited serious morbidity.
The trend showed a considerable increase in GUCH
patients worldwide. In Netherland, the population
estimated to be of GUCH disease patients will reach
20,000 in coming years.5 Such an increasing trend is
observed in other developed countries as well and
reports from Canada and the United Kingdom (UK) have
shown significant rise in GUCH compared to paediatric
patients.6 A survey in UK spanning over a decade
predicted the annual rise of GUCH population to be 1600
withmore than half of the patients having complex lesion,
and thus demanding special care in follow-up by the
attending physicians.7 Another study from UK reported a
decline in number of simple procedures from 46% to 28%
and there is increase in number of re-operative surgeries
in GUCH patients. Most of them are undergoing surgery
for complex lesions or surgery for residual or sequel of
previous corrective or palliative procedure.8 Surgical
procedures like coronary artery bypass grafting, aortic
root surgery for connective tissue disorder, valve
replacement and Maze procedure for ablation of
refractory tachydysrhythmias are some of the complex
procedures performed in GUCH patients.9 We know now
that no surgical "correction" exists for CHD and all such
surgical modalities are palliative surgeries that require
surgical sequel in near or far future, for example
pulmonary regurgitation with right ventricular
dysfunction is a common complication after reparative
surgery of TOF.10 In our country with the development of
paediatric congenital cardiac surgical programmes, a
number of adults with congenital lesion are being
discovered and are seeking advice for treatment. In our
series, similar rising trends have been observed over the
years (Figure).
However, contrary to the west we are operating for simple
procedure like ASD and VSD and we still have a population
of patient who grow up with their lesions considering
inoperable or with the false belief that it will go away with
time. It is call of the time for countries like Pakistan to have
well-defined guidelines and policies for developing
dedicated centres in this regard. Such centres will be
equippedwith resources that will especially focus attention
on the complex anatomy, physiology, biochemistry and
more often psychiatry of GUCH patients. We at present do
not have dedicated facilities for GUCH patients. This report
highlights the fact that most of these simple lesions should
have been treated before reaching adulthood.
Since most of the congenital lesions are not totally
corrected, we should be ready to face them as GUCH
patients with more complex issues as already faced in
most of the developed countries.
Disclaimer: The study was presented as Poster at the 6th
World Congress of Paediatric Cardiology and Cardiac
Surgery (Feb. 17-22, 2013) at Cape Town, South Africa.
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